Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.
about
Recent insights into the biological activities and drug delivery systems of tanshinonesPreparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Tanshinones: sources, pharmacokinetics and anti-cancer activitiesProperties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity.Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicineOral bioavailability: issues and solutions via nanoformulations.PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.Effect of squalane on mebendazole-loaded Compritol® nanoparticles.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability.Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles.Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
P2860
Q26770498-39DF4E67-6F23-414E-8220-D3BDBF3A634AQ30464963-A752DC27-1486-4DBB-94AF-8B997DCEBF0DQ34733880-F5556108-92F1-4AE1-A3E5-BCDA94AF42F1Q36396623-6E0CE8D5-6410-4761-90EF-1E4CD2C6182CQ37805491-110D0A05-1303-47B9-9425-650510512407Q37914880-EB49A1C9-098B-4071-87E1-DBB8927E20AAQ38112162-1A9F6B37-E51B-4302-AD8B-16DD20D24939Q38245647-93ED8EB4-A4FA-4D36-8FB2-539F8A538324Q38349734-F77DCB0A-B34D-4778-9AF6-FA7B3CCC56F5Q38976681-92AD5765-3BD1-496E-AD79-0DBD20DAA82BQ38997074-DEA18B6F-6696-48B6-81B9-EA6E43315B77Q39518383-8FBB6035-13DB-4D5D-9733-34CFBA6B200BQ40335962-BF745E08-A059-46AE-BF2A-FB6A27F25CEEQ48345993-A1FBA161-B9AB-4E7F-8538-C2661204E5F9Q49058125-5E441300-4C37-4872-9A15-1F1D55751ACFQ50094521-479F639E-962C-4D09-96B0-432E674B1BA2
P2860
Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@ast
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@en
type
label
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@ast
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@en
prefLabel
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@ast
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@en
P2093
P2860
P1433
P1476
Preparation and enhanced oral ...... ded solid lipid nanoparticles.
@en
P2093
Chuang Shang
LianDong Hu
Qianbin Xing
P2860
P2888
P304
P356
10.1208/S12249-010-9410-3
P407
P577
2010-03-30T00:00:00Z
P6179
1039273616